ZLAB Q2 2025 Earnings — Zai Lab Limited Revenue & Financial Results | Market Cap Arena

ZLABZai Lab Limited

$2B

Q2 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$110M+9.4% YoY

Gross Profit

$67M60.7% margin

Operating Income

-$55M-49.9% margin

Net Income

-$41M-37.0% margin

EPS (Diluted)

$-0.37

QoQ Revenue Growth

+3.3%

Cash Flow

Operating Cash Flow

-$31M

Free Cash Flow

-$32M

Stock-Based Comp.

$17M

Balance Sheet

Total Assets

$1.2B

Total Liabilities

$372M

Stockholders' Equity

$792M

Cash & Equivalents

$732M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$110M	$101M	+9.4%
Gross Profit	$67M	$65M	+2.3%
Operating Income	-$55M	-$76M	+27.8%
Net Income	-$41M	-$80M	+49.3%

Revenue Segments

Zejula

$41M54%

Nuzyra

$14M19%

Optune

$12M16%

Qinlock

$9M11%

Product and Service, Other

$342,0000%